Author(s): Esha Yadav, Sagar Singh, Pratima Kumari, Sachin Singh Rathore, Khushi Gupta, Vaishali

Email(s): ssingh99756@gmail.com

DOI: 10.52711/2231-5691.2024.00039   

Address: Esha Yadav2, Sagar Singh3*, Pratima Kumari1, Sachin Singh Rathore1, Khushi Gupta1, Vaishali1
1Research Scholar, Department of Pharmacy, Axis Institute of Pharmacy, Kanpur, U.P., India.
2Head of Department, Department of Pharmacy, Axis Institute of Pharmacy, Kanpur, U.P., India.
3Assistant Professor, Department of Pharmacy, Axis Institute of Pharmacy, Kanpur, U.P., India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 3,     Year - 2024


ABSTRACT:
In this review, we summarize the researches on animal reservoirs of the SARS corona virus (SARS-CoV). Masked palm civets had been suspected because the foundation of the SARS outbreak in 2003 and turned into showed because the direct foundation of SARS instances with slight symptom in 2004. Sequence evaluation of the SARS-CoV-like virus in masked palm civets indicated that they had been exceedingly homologous to human SARS-CoV with, identification over 99.6%, indicating the virus has now no longer been circulating with inside the population of masked palm civets for a totally lengthy time. Alignment of 10 entire viral genome sequences from masked palm civets with the ones of human SARS-CoVs found out 26 conserved single- nucleotide variations (SNVs) with inside the viruses from masked palm civets. These conserved SNVs had been step by step misplaced from the genomes of viruses remoted from the early section to overdue section human sufferers of the 2003 SARS epidemic. In 2005, horseshoe bats had been recognized because the herbal reservoir of a set of corona viruses which can be distantly associated with SARS-CoV. The genome sequences of bat SARS-like corona virus had approximately 88–92% identification with that of the SARS-CoV. The incidence of antibodies and viral RNA in special bat species and the traits of the bat SARS-like corona virus had been elucidated. Apart from masked palm civets and bats, 29 different animal species were examined for the SARS-CoV, and the outcomes are summarized on this paper. Corona viruses (CoV) are a massive own circle of relatives of viruses inflicting a spectrum of sickness starting from the 22 not unusual place bloodless to greater intense illnesses as Middle East Respiratory Syndrome (MERS-CoV) and 23 Severe Acute Respiratory Syndrome (SARS-CoV). The current outbreak of corona virus sickness 24 2019 (COVID-19) has come to be a public fitness emergency worldwide. SARS-CoV-2, the virus 25 accountable for COVID-19, is unfolded through human- to-human transmission through droplets or direct 26contact.


Cite this article:
Esha Yadav, Sagar Singh, Pratima Kumari, Sachin Singh Rathore, Khushi Gupta, Vaishali. A Review on Characterization of SARS-COVID-19-2 Omicron (B.1.1.529) and JN.1 Variant of Concern and its Global Perspective. Asian Journal of Pharmaceutical Research. 2024; 14(3):255-2. doi: 10.52711/2231-5691.2024.00039

Cite(Electronic):
Esha Yadav, Sagar Singh, Pratima Kumari, Sachin Singh Rathore, Khushi Gupta, Vaishali. A Review on Characterization of SARS-COVID-19-2 Omicron (B.1.1.529) and JN.1 Variant of Concern and its Global Perspective. Asian Journal of Pharmaceutical Research. 2024; 14(3):255-2. doi: 10.52711/2231-5691.2024.00039   Available on: https://asianjpr.com/AbstractView.aspx?PID=2024-14-3-8


REFERENCES:
1.    Ebrahim Alinia-Ahandani, Milad Sheydaei. Overview of the Introduction to the New Coronavirus (Covid19). 2020; 6(2).
2.    Ciota AT, Ngo KA, Lovelace AO, Payne AF, Zhou Y, Shi PY (2007). Role of the mutant spectrum in adaptation and replication of West Nile virus. J. Gen Virol.88:865–874.
3.    Alinia-Ahandani E, Fazilati M, Alizadeh Z, Boghozian A (2018). The introduction of some mushrooms as an effective source of medicines in Iran Northern. Biol. Med., 10.
4.    Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan Y, Fang C, Huang D, Huang L, Huang Q, Han Y, Hu B, Hu F, Li B, Li Y, Liang K, Lin L, Luo L, Ma J, Ma L, Peng Z, Pan Y, Pan Z, Ren X, Sun H, Wang Y, Wang Y, Weng H, Wei C, Wu D, Xia J, Xiong Y, Xu H, Yao X, Yuan Y, Ye T, Zhang X, Zhang Y, Zhang Y, Zhang H, Zhao Y, Zhao M, Zi H, Zeng X, Wang Y, Wang X (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 7(1).
5.    Daniel L and Annie S (January 2020). China Deserves Some Credit for Its Handling of the wuhan Pneumonia. Foreign Policy. Retrieved 13 March2020.
6.    Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, Rubin SA (2006). Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology. 2006; 350:48–57.
7.    Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L, Wang M (21 February 2020). Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA.doi:10.1001/jama.2020.2565.
8.    Alinia-Ahandani E, Fazilati M, Alizadeh Z, Boghozian A (2018). The introduction of some mushrooms as an effective source of medicines in Iran Northern. Biol. Med., 10. 10.4172/0974-8369.1000451.
9.    F. Pan, T. Ye, P. Sun, S. Gui, B. Liang, L. Li, et al., Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia, Radiology (2020)200370,
10.    A.R. Shin, A. Endogen, P.M. Agaoglu, Y. Dineri, A.Y. Cakirci, M.E. Senel, et al., 2019 Novel Corona virus (COVID-19) outbreak: A review of the current literature, Eurasian J. Med. Oncol. 4 (2020)1-7.
11.    Y. Chen, Q. Liu, D. Guo, Emerging coronaviruses: genome structure, replication, and pathogenesis, J. Med. Virol. 92 (2020) 418-423.https://doi.org/10.1002/jmv.25681.
12.    J. Wu, J. Liu, X. Zhao, C. Liu, W. Wang, D. Wang, et al., Clinical characteristics of imported cases of covid-19 in jiangsu province: A multicenter descriptive study, Clin. Infect. Dis.(2020).
13.    C. Sohrabi, Z. Alsafi, N. O'Neill, M. Khan, A. Kerwan, A. Al-Jabir, et al., World Health Organization declares global emergency: A review of the 2019 novel corona virus (COVID-Int. J.Surg. 76 (2020)71-76.
14.    Y.H. Jin, L. Cai, Z.S. Cheng, H. Cheng, T. Deng, Y.P. Fan, et al., A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version), Mil. Med. Res. 7 (2020)4.
15.    Z.Y. Zu, M.D. Jiang, P.P. Xu, W. Chen, Q.Q. Ni, G.M. Lu, et al., Coronavirus Disease 2019 (COVID-19): A perspective from China, Radiology (2020)200490,
16.    P. Habibzadeh, E.K. Stoneman, The novel coronavirus: A bird's eye View, Int. J. Occup. Environ. Med. 11 (2020) 65, https://doi.org/10.15171/ijoem.2020.1921.
17.    C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 395 (2020)497-506.
18.    W. Wang, Y. Xu, R. Gao, R. Lu, K. Han, G. Wu, et al., Detection of SARS-CoV-2 in different types of clinical specimens, JAMA(2020), https://doi.org/10.1001/jama.2020.3786.
19.    X. Xie, Z. Zhong, W. Zhao, C. Zheng, F. Wang, J. Liu, Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing, Radiology(2020).
20.    Y. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS, J Virol. 94 (2020)e00127-20,
21.    H. Jia, Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease, Shock, J. Virol. 46 (2016) 239-248, https://doi.org/10.1128/JVI.00127-20.
22.    Y. Cao, L. Li, Z. Feng, S. Wan, P. Huang, X. Sun, et al., Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations, Cell Discov. 6 (2020) 1-4
23.    Y. Wu, Compensation of ACE2 function for possible clinical management of 2019-ncov- induced acute lung injury, Virol. Sin. (2020) 1-3, https://doi.org/10.1007/s12250-020- 00205-6.
24.    J. Qiao, What are the risks of COVID-19 infection in pregnant women?, Lancet 395(2020)760-762, .
25.    X. Yu, Q. Lin, X. Qin, Z. Ruan, J. Zhou, Z. Lin, et al., ACE2 antagonizes VEGFa to reduce Vascular permeability during acute lung injury, Cell Physiol. Biochem. 38 (2016) 1055-1062.
26.    P. Yang, H. Gu, Z. Zhao, W. Wang, B. Cao, C. Lai, et al., Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury, Sci. Rep. 4 (2014)7027.
27.    L. Dong, S. Hu, J. Gao, Discovering drugs to treat coronavirus disease 2019 (COVID- 19), Drug Discov. Ther. 14 (2020) 58-60, https://doi.org/10.5582/ddt.2020.01012.
28.    T. Smith, T. Prosser, COVID-19 Drug Therapy–potential options. Clinical Drug Information|Clinical Solutions, in, Elsevier, 2020.
29.    Y. Imai, K. Kuba, S. Rao, Y. Huan, F. Guo, B. Guan, et al., Angiotensin-converting enzyme to protects from severe acute lung failure, Nature 436 (2005)112-116,
30.    Marano G., Vaglio S., Pupella S. Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus.2016; 14(2):152–157.



Recomonded Articles:

Author(s): Mukul Ahmed, Ravikumar, Narayanaswamy VB, Injamamul Haque, Mohibul Hoque

DOI: 10.5958/2231-5691.2016.00020.4         Access: Open Access Read More

Author(s): Batra Neha, Jain Honey, Bairwa Ranjan, Bachwani Mukesh

DOI:         Access: Open Access Read More

Author(s): Shah Murad, Seema, A Ghaffar, G Mujtaba Abbasi, Ijaz Ur Rehman, Abdul Qadir

DOI: 10.5958/2231-5691.2019.00024.8         Access: Open Access Read More

Author(s): Prathibha Suvarna, Ravi Kumar, Yamunappa, Pooja Shetty, Narayana Swamy V.B.

DOI: 10.5958/2231-5691.2016.00003.4         Access: Open Access Read More

Author(s): Dhanashri Aware, Sachin Rohane

DOI: 10.52711/2231-5691.2021.00037         Access: Open Access Read More

Author(s): Kumbhar Swapnil, Salunkhe Vijay , Magdum Chandrakant

DOI:         Access: Open Access Read More

Author(s): D. Sunitha, P. Anusri, M. Sudhakar

DOI: 10.5958/2231-5691.2019.00048.0         Access: Open Access Read More

Author(s): Kishan L. Jadhav, Priyanka R. Kapare, Divya V. Khairmode, Chaitali H. Keskar1, Farida Shaikh, Shradda Sawant, Akash S. Mali

DOI: 10.5958/2231-5691.2018.00031.X         Access: Open Access Read More

Author(s): Praveen Radhakrishnan, Shinu Chacko

DOI: 10.5958/2231-5691.2018.00032.1         Access: Open Access Read More

Author(s): Deepa Amminbavi, N Prasanna Lakshmi

DOI: 10.5958/2231-5691.2020.00013.1         Access: Open Access Read More

Author(s): Betsy Joseph, Anuradha V. P, Jayakrishnan S. S, Ajith B

DOI: 10.5958/2231-5691.2019.00027.3         Access: Open Access Read More

Author(s): Asija Rajesh, Bansal Vishnu, Asija Sangeeta, Rathore Suryabhan Singh

DOI:         Access: Open Access Read More

Author(s): K.V.M. Krishna, Lakshmi SVVNSM, Alluri Ramesh, Rajendra Prasad

DOI:         Access: Open Access Read More

Author(s): Vaishnavi. K. Patil, Azam. Z. Shaikh

DOI: 10.5958/2231-5691.2020.00048.9         Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags